Dr. Steven Andrew Schulz, MD

Dr. Schulz practices at Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health.

Dr. Schulz's NPI, 1740418615, was assigned on June 30, 2009. Dr. Schulz graduated from Northeastern Ohio University College of Medicine in 2009. Dr. Schulz holds Ohio license 35121739.

Dr. Schulz's primary practice is Prisma Health Hillcrest Hospital, at 741 South East Main Street, Simpsonville, SC 29681 in Greenville County. The practice phone is (864) 454-6100. Dr. Schulz also practices at Hillcrest Hospital, 6780 Mayfield Rd, Cleveland, OH 44124.

Dr. Schulz's primary practice is Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health. Dr. Schulz is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Schulz to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schulz practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Schulz's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Schulz is licensed in Ohio.

CMS data shows 71 Medicare services from Dr. Schulz across 3 procedure codes in 2024, all of them office visits, for 97 Medicare patients. Medicare paid $4,349 for them.

CMS counts 97 Medicare patients who saw Dr. Schulz in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schulz's median patient age at 55, with 73% women.

In 2024, Dr. Schulz wrote 17 Medicare Part D claims for 12 patients. 94% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $175 in total drug cost.

Dr. Schulz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schulz as offering telehealth. CMS counts 12 procedures of melanoma (skin cancer) excision by Dr. Schulz, more than 66% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Schulz, published from 2017 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Mammaplasty, Breast Neoplasms and Mastectomy. Dr. Schulz has published most often in Eplasty. Dr. Schulz's most frequent co-authors are Bradon J. Wilhelmi, MD, Joshua Hyosung Choo, MD and Amy Marcelle Moore, MD.

CMS Open Payments shows 79 general payments to Dr. Schulz from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. AxoGen paid the most, $2,247.

Dr. Schulz graduated from Northeastern Ohio University College of Medicine in 2009.